Lutein Iontophoresis in Intermediate AMD and Reticular Pseudodrusen - a Retrospective Study

Inclusion criteria * Age between 55 and 80 years old * diagnosis of early to intermediate stage dAMD (based on AREDS criteria) * presence of RPD * Treated with scleral Lutein Iontophoresis Exclusion Criteria: * GA or MNV in the included eye * any prior or any ongoing medical or surgical treatment of the included eye (including intravitreal injections, oral supplementation of lutein, zeaxanthin and or high dietary intake of antioxidants) * smokers (consummation of more than 20 cigarettes per day) * history of treatment with drugs with a well-known possible ophthalmic side-effect * known eye diseases such glaucoma, acute or chronic uveitis, advanced cataract, stage 4 dry eye disease or any opacities of the ocular media that do not permit high-quality imaging examinations * manifest refraction outside of -6 and +4 dioptres * BCVA \< 40 EDTRS letters.